Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Commercial Physical & Biological Resarch industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Commercial Physical & Biological Resarch industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Commercial Physical & Biological Resarch industry Largest Companies List by Market Cap as of August 2026

  1. IQVIA Holdings

    World Rank (Aug-2026)
    676
    Market Cap (Aug-2026)
    38.954 Billion USD
    World Rank (Jan-05-2024)
    450
    Market Cap (Jan-05-2024)
    40.165 Billion USD
    World Rank (Jul-30-2023)
    435
    Market Cap (Jul-30-2023)
    41.962 Billion USD
    World Rank (Dec-25-2022)
    436
    Market Cap (Dec-25-2022)
    37.861 Billion USD
    World Rank (Jan-07-2022)
    396
    Market Cap (Jan-07-2022)
    49.08 Billion USD
    Annual Revenue in USD
    16,310 Million USD
    Annual Operating Income in USD
    2,182 Million USD
    Annual Net Income in USD
    1,360 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    IQVIA HOLDINGS provides Data, Clinical Trails Data, Information, Analytics and Technology to Healthcare Companies. Headquarters is in USA.IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.

    Facts About Company

    IQVIA HOLDINGS annual revenue generated for period ending Dec-2022 was 14,410 million USD.

    IQVIA HOLDINGS annual net income generated for period ending Dec-2022 was 1,091 million USD.

  2. Incyte Corporation

    World Rank (Aug-2026)
    1,044
    Market Cap (Aug-2026)
    24.356 Billion USD
    World Rank (Jan-05-2024)
    1,185
    Market Cap (Jan-05-2024)
    14.923 Billion USD
    World Rank (Jul-30-2023)
    1,265
    Market Cap (Jul-30-2023)
    14.075 Billion USD
    World Rank (Dec-25-2022)
    918
    Market Cap (Dec-25-2022)
    18.101 Billion USD
    World Rank (Jan-07-2022)
    1,253
    Market Cap (Jan-07-2022)
    16.17 Billion USD
    Annual Revenue in USD
    5,141 Million USD
    Annual Operating Income in USD
    1,515 Million USD
    Annual Net Income in USD
    1,287 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Incyte Corporation is a Bio-Pharmaceutical company with headquarters is in Delaware, USA.

    As on 2021, Incyte Corporation has 2,094 employees, 989 are in research and development, 187 in medical affairs, 638 in sales and marketing and 280 in operations support, finance and administrative positions.

    As on 2022, Incyte Corporation has 2,324 employees.

    Incyte Corporation annual revenue generated for period ending Dec-2022 was 3,394 million USD.

  3. Medpace Holdings

    World Rank (Aug-2026)
    1,482
    Market Cap (Aug-2026)
    16.147 Billion USD
    World Rank (Jan-05-2024)
    1,782
    Market Cap (Jan-05-2024)
    9.093 Billion USD
    World Rank (Jul-30-2023)
    2,061
    Market Cap (Jul-30-2023)
    7.771 Billion USD
    World Rank (Dec-25-2022)
    2,151
    Market Cap (Dec-25-2022)
    6.616 Billion USD
    World Rank (Jan-07-2022)
    2,575
    Market Cap (Jan-07-2022)
    6.76 Billion USD
    Annual Revenue in USD
    2,530 Million USD
    Annual Operating Income in USD
    535 Million USD
    Annual Net Income in USD
    451 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Medpace Holdings clinical research, therapeutic and specialty areas are autoimmune diseases, cardiovascular, endocrine and metabolic, hematology and oncology, infectious diseases and vaccines, nephrology, neuroscience, pediatrics, rare disease and orphan indications and advanced therapies. The headquarters is in USA.

  4. Charles River Laboratories International

    World Rank (Aug-2026)
    1,745
    Market Cap (Aug-2026)
    13.369 Billion USD
    World Rank (Jan-05-2024)
    1,471
    Market Cap (Jan-05-2024)
    11.492 Billion USD
    World Rank (Jul-30-2023)
    1,589
    Market Cap (Jul-30-2023)
    10.773 Billion USD
    World Rank (Dec-25-2022)
    1,409
    Market Cap (Dec-25-2022)
    11.117 Billion USD
    World Rank (Jan-07-2022)
    1,223
    Market Cap (Jan-07-2022)
    16.59 Billion USD
    Annual Revenue in USD
    4,015 Million USD
    Annual Operating Income in USD
    25 Million USD
    Annual Net Income in USD
    -144 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Charles River Laboratories is a Healthcare and pharmaceutical company. The company products and services are Research animals models, genetically engineered model and services, animal health, surveillance, surgery and precondition service, generic testing services and Insourcing solutions. The headquarters is in USA.

    The company currently operated 110 facilities in 20 countries.

    Facts About Company

    Charles River Laboratories annual revenue generated for period ending Dec-2022 was 3,976 million USD.

    Charles River Laboratories annual net income generated for period ending Dec-2022 was 486 million USD.

    Charles River Laboratories annual revenue generated for period ending Dec-2021 was 3,540 million USD.

    Charles River Laboratories annual net income generated for period ending Dec-2021 was 391 million USD.

  5. ICON Public Company

    World Rank (Aug-2026)
    1,852
    Market Cap (Aug-2026)
    12.492 Billion USD
    World Rank (Jan-05-2024)
    828
    Market Cap (Jan-05-2024)
    22.125 Billion USD
    World Rank (Jul-30-2023)
    897
    Market Cap (Jul-30-2023)
    20.657 Billion USD
    World Rank (Dec-25-2022)
    1,046
    Market Cap (Dec-25-2022)
    15.909 Billion USD
    World Rank (Jan-07-2022)
    935
    Market Cap (Jan-07-2022)
    22.37 Billion USD
    Annual Revenue in USD
    7,733 Million USD
    Annual Operating Income in USD
    877 Million USD
    Annual Net Income in USD
    506 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. They have 13,680 employees in 37 countries across 37 countries

Share

Ads